Carolyn M. Bruguera, Esq.
1 blog from the author
Posted on 21.04.2015
Beefing up safeguards against corruption: Where is the medtech industry in 2015?
Eight years ago, I was interviewing executives of a prospective Chinese distributor for my employer, a publicly-traded medical device company based in California. “We understand that it is hard to do business in China without paying kickbacks to physicians and hospital administrators” I observed. “How do you handle this?” Without hesitating, one of the executives […]